The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
Open accessAbstract
Uncontrolled and controlled clinical trials with different compounds and procedures are reviewed to define the risk-benefit profiles for therapeutic options in pulmonary arterial hypertension (PAH). A grading system for the level of evidence of treatments based on the controlled clinical trials performed with each compound is used to propose an evidence-based treatment algorithm. The algorithm includes drugs approved by regulatory agencies for the treatment of PAH and/or drugs available for other indications. The different treatments have been evaluated mainly in idiopathic PAH, heritable PAH, and in PAH associated with the scleroderma spectrum of diseases or with anorexigen use. Extrapolation of these recommendations to other PAH subgroups should be done with caution. Oral anticoagulation is proposed for most patients; diuretic treatment and supplemental oxygen are indicated in cases of fluid retention and hypoxemia, respectively. High doses of calcium channel blockers are indicated only in the minority of patients who respond to acute vasoreactivity testing. Nonresponders to acute vasoreactivity testing, or responders who remain in World Health Organization (WHO) functional class III, should be considered candidates for treatment with either an oral phosphodiesterase-5 inhibitor or an oral endothelin-receptor antagonist. Continuous intravenous administration of epoprostenol remains the treatment of choice in WHO functional class IV patients. Combination therapy is recommended for patients treated with PAH monotherapy who remain in New York Heart Association functional class III. Atrial septostomy and lung transplantation are indicated for refractory patients or where medical treatment is unavailable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Self-citationSildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationIncidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationTreatment of Pulmonary Arterial Hypertension
Humbert, M., Sitbon, O., & Simonneau, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040291 · Cited by 1,707
Self-citationThe Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citationSIMONNEAU, G., BARST, R. J., GALIE, N., NAEIJE, R., RICH, S., BOURGE, R. C., KEOGH, A., OUDIZ, R., FROST, A., BLACKBURN, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,441
Self-citationLong-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Self-citationGaliè, N., Torbicki, A., Barst, R. J., Dartevelle, P., Haworth, S. G., Higenbottam, T., Olschewski, H., Peacock, A. J., Pietra, G., Rubin, L. J., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.014 · Cited by 1,194
Self-citationChronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., & Rubin, L. J. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,148
Self-citationNatural history of pulmonary embolism
Dalen, J. E., & Alpert, J. S. (1975) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(75)80017-x · Cited by 1,124
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Self-citationGaliè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,083
Self-citationBadesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,075
Self-citationPrimary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V, Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., & Frye, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,066
Galiè, N., Rubin, L., Hoeper, M., Jansa, P., Al-Hiti, H., Meyer, G., Chiossi, E., Kusic-Pajic, A., & Simonneau, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60919-8 · Cited by 920
Self-citationGaliè, N., Beghetti, M., Gatzoulis, M. A., Granton, J., Berger, R. M. F., Lauer, A., Chiossi, E., & Landzberg, M. (2006) · Circulation · doi:10.1161/circulationaha.106.630715 · Cited by 843
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases
Jamieson, S. W., Kapelanski, D. P., Sakakibara, N., Manecke, G. R., Thistlethwaite, P. A., Kerr, K. M., Channick, R. N., Fedullo, P. F., & Auger, W. R. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00828-2 · Cited by 770
Chronic Thromboembolic Pulmonary Hypertension
Fedullo, P. F., Auger, W. R., Kerr, K. M., & Rubin, L. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010902 · Cited by 769
Self-citationRubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 706
Self-citationSitaxsentan Therapy for Pulmonary Arterial Hypertension
Barst, R. J., Langleben, D., Frost, A., Horn, E. M., Oudiz, R., Shapiro, S., McLaughlin, V., Hill, N., Tapson, V. F., Robbins, I. M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-957oc · Cited by 706
Self-citationA meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Galie, N., Manes, A., Negro, L., Palazzini, M., Bacchi-Reggiani, M. L., & Branzi, A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp022 · Cited by 651
Galiè, N., Humbert, M., Vachiéry, J.-L., Vizza, C., Kneussl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 648
Self-citationCombination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 640
Self-citationBeraprost therapy for pulmonary arterial hypertension
Barst, R. J., McGoon, M., McLaughlin, V., Tapson, V., Oudiz, R., Shapiro, S., Robbins, I. M., Channick, R., Badesch, D., Rayburn, B. K., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00463-7 · Cited by 631
Self-citationRandomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 626
Self-citationSimonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 616
Self-citationBosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Jaïs, X., D'Armini, A. M., Jansa, P., Torbicki, A., Delcroix, M., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Mayer, E., Pepke-Zaba, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.059 · Cited by 550
Self-citationAmbrisentan Therapy for Pulmonary Arterial Hypertension
Galié, N., Badesch, D., Oudiz, R., Simonneau, G., McGoon, M. D., Keogh, A. M., Frost, A. E., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 494
Self-citationClinical efficacy of sildenafil in primary pulmonary hypertension
Sastry, B. K. S., Narasimhan, C., Reddy, N. K., & Raju, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.056 · Cited by 488
Barst, R. J., Langleben, D., Badesch, D., Frost, A., Lawrence, E. C., Shapiro, S., Naeije, R., & Galie, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.057 · Cited by 478
Self-citationGoal-oriented treatment and combination therapy for pulmonary arterial hypertension
Hoeper, M. M., Markevych, I., Spiekerkoetter, E., Welte, T., & Niedermeyer, J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00075305 · Cited by 468
Self-citationRisk factors for chronic thromboembolic pulmonary hypertension
Bonderman, D., Wilkens, H., Wakounig, S., Schäfers, H.-J., Jansa, P., Lindner, J., Simkova, I., Martischnig, A. M., Dudczak, J., Sadushi, R., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087608 · Cited by 441
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
Barst, R. J., Maislin, G., & Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1197 · Cited by 427
Self-citationBecattini, C., Agnelli, G., Pesavento, R., Silingardi, M., Poggio, R., Taliani, M. R., & Ageno, W. (2006) · Chest · doi:10.1378/chest.130.1.172 · Cited by 414
Jego, P. (1996) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)83752-0 · Cited by 409
Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
Condliffe, R., Kiely, D. G., Gibbs, J. S. R., Corris, P. A., Peacock, A. J., Jenkins, D. P., Hodgkins, D., Goldsmith, K., Hughes, R. J., Sheares, K., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1841oc · Cited by 400
Self-citationGaliè, N., Hinderliter, A. L., Torbicki, A., Fourme, T., Simonneau, G., Pulido, T., Espinola-Zavaleta, N., Rocchi, G., Manes, A., Frantz, R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00121-9 · Cited by 378
Self-citationRich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V., & Francis, G. (1998) · Chest · doi:10.1378/chest.114.3.787 · Cited by 371
Self-citationLong-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Self-citationGraded balloon dilation atrial septostomy in severe primary pulmonary hypertension
Sandoval, J., Gaspar, J., Pulido, T., Bautista, E., Martínez-Guerra, M. L., Zeballos, M., Palomar, A., & Gómez, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00238-1 · Cited by 356
Long-Term Outcome after Pulmonary Thromboendarterectomy
ARCHIBALD, C. J., AUGER, W. R., FEDULLO, P. F., CHANNICK, R. N., KERR, K. M., JAMIESON, S. W., KAPELANSKI, D. P., WATT, C. N., & MOSER, K. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9808109 · Cited by 315
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
Bonderman, D., Jakowitsch, J., Adlbrecht, C., Schemper, M., Kyrle, P., Schönauer, V., Exner, M., Klepetko, W., Kneussl, M., Maurer, G., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0657 · Cited by 296
Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension
Tapson, V. F., Gomberg-Maitland, M., McLaughlin, V. V., Benza, R. L., Widlitz, A. C., Krichman, A., & Barst, R. J. (2006) · Chest · doi:10.1378/chest.129.3.683 · Cited by 294
Self-citationCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H., Halank, M., Wilkens, H., Meyer, F. J., Seyfarth, H. J., Wensel, R., Ripken, F., Bremer, H., Kluge, S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 288
Self-citationLong-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension
Suntharalingam, J., Treacy, C. M., Doughty, N. J., Goldsmith, K., Soon, E., Toshner, M. R., Sheares, K. K., Hughes, R., Morrell, N. W., & Pepke-Zaba, J. (2008) · Chest · doi:10.1378/chest.07-2681 · Cited by 269
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension
Kerstein, D., Levy, P. S., Hsu, D. T., Hordof, A. J., Gersony, W. M., & Barst, R. J. (1995) · Circulation · doi:10.1161/01.cir.91.7.2028 · Cited by 255
Self-citationChronic Thromboembolic Pulmonary Hypertension — Not So Rare after All
Lang, I. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048088 · Cited by 253
Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension
Keogh, A. M., Mayer, E., Benza, R. L., Corris, P., Dartevelle, P. G., Frost, A. E., Kim, N. H., Lang, I. M., Pepke-Zaba, J., & Sandoval, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.016 · Cited by 248
Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension
McLaughlin, V. V., Gaine, S. P., Barst, R. J., Oudiz, R. J., Bourge, R. C., Frost, A., Robbins, I. M., Tapson, V. F., McGoon, M. D., Badesch, D. B., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200302000-00019 · Cited by 232
Self-citationSplenectomy and chronic thromboembolic pulmonary hypertension
Jais, X. (2005) · Thorax · doi:10.1136/thx.2004.038083 · Cited by 228
Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension
Gomberg-Maitland, M., Tapson, V. F., Benza, R. L., McLaughlin, V. V., Krichman, A., Widlitz, A. C., & Barst, R. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-766oc · Cited by 222
Self-citationNocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome
SANDOVAL, J., AGUIRRE, J. S., PULIDO, T., MARTINEZ-GUERRA, M. L., SANTOS, E., ALVARADO, P., ROSAS, M., & BAUTISTA, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2106076 · Cited by 213
Egermayer, P., & Peacock, A. J. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15.03.x · Cited by 177
Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil
Burgess, G., Hoogkamer, H., Collings, L., & Dingemanse, J. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0408-z · Cited by 151
Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review
Johnson, S. R., Mehta, S., & Granton, J. T. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00015206 · Cited by 147
Simonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., & Frost, A. (2009) · Annals of Internal Medicine · Cited by 129
Self-citationBonderman, D., Jakowitsch, J., Redwan, B., Bergmeister, H., Renner, M.-K., Panzenboeck, A., Adlbrecht, C., Georgopoulos, A. P., Klepetko, W., Kneußl, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156000 · Cited by 124
Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects
Wrishko, R. E., Dingemanse, J., Yu, A., Darstein, C., Phillips, D. L., & Mitchell, M. I. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008315315 · Cited by 118
Peacock, A., Simonneau, G., & Rubin, L. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-114lr · Cited by 108
Self-citationMedical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
Bresser, P., Pepke-Zaba, J., Jaïs, X., Humbert, M. J. C., & Hoeper, M. M. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-115lr · Cited by 105
Self-citationSkoro‐Sajer, N., Hack, N., Sadushi‐Kolici, R., Bonderman, D., Jakowitsch, J., Klepetko, W., Hoda, M. A. R., Kneußl, M., Fedullo, P. F., & Lang, I. M. (2009) · Circulation · doi:10.1161/circulationaha.108.794610 · Cited by 97
Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension
Kim, N. H. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-106lr · Cited by 94
Langleben, D., Christman, B. W., Barst, R. J., Dias, V. C., Galiè, N., HIGENBOTTAM, T. W., Kneußl, M., Korducki, L., Naeije, R., Riedel, A., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121806 · Cited by 90
Self-citationPharmacokinetics and Safety of Ambrisentan in Combination With Sildenafil in Healthy Volunteers
Spence, R., Mandagere, A., Dufton, C., & Venitz, J. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008324180 · Cited by 80
Mellemkjær, S., Ilkjær, L. B., Klaaborg, K. E., Christiansen, C. L., Severinsen, I. K., Nielsen‐Kudsk, J. E., Allermand, H., Egeblad, M., & Kristensen, B. Ø. (2005) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430500338513 · Cited by 44
Cited by
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationGuidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Self-citationUpdated Treatment Algorithm of Pulmonary Arterial Hypertension
Galiè, N., Corris, P. A., Frost, A., Girgis, R. E., Granton, J., Jing, Z. C., Klepetko, W., McGoon, M. D., McLaughlin, V. V., Preston, I. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.031 · Cited by 667
Self-citationSoluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Metadata
- Authors
- Barst, R. J., Gibbs, J. S. R., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V. V., Rubin, L. J., Sitbon, O., Tapson, V. F., & Galiè, N.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 54
- Issue
- 1
- Pages
- S78-S84
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2142743112
- Cited by
- 499
- References
- 70
- FWCI
- 64.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.